Saturday, February 18, 2006


Hepatitis C Information - Koronis Pharmaceuticals to Participate in Panel 'Infectious ...


Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Enzo Biochem Shareholders Elect Three Directors at Annual Meeting
Genetic Engineering News, NY - Jan 19, 2006... of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn's ...

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in ...
RxPG NEWS, CA - Jan 18, 2006... in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C infection," said Steven W ...

Peregrine accelerates Tarvacin development
Pharmaceutical Business Review - Jan 19, 2006... Peregrine. In the phase I trial, a single dose of Tarvacin is being tested in patients with chronic hepatitis C infection. Data ...

Friday, February 17, 2006


Hepatitis C Information - Molecular mechanism that inhibits HCV replication discovered - Tang


Molecular mechanism that inhibits HCV replication discovered - Tang
RxPG - By Florida State University, The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. Since its discovery several decades ago, the insidious human pathogen has stymied the quest

Interesting Findings from fMRI Scans of Political Brains
RxPG - By Emory University Health Sciences Center, When it comes to forming opinions and making judgments on hot political issues, partisans of both parties don't let facts get in the way of their decision-making, according to a new Emory University study

Third Wave settles with Belgian firm
Milwaukee Business Journal - Third Wave (NASDAQ: TWTI) and Innogenetics N.V. said the two firms have reached an agreement that will allow Madison-based Third Wave to sell the genotyping products in the United States under a non-exclusive license. Innogenetics had sued Third Wave

Home paper shredders pose serious injury risk to toddlers
RxPG - By New York University Medical Center and School of Medicine, As our environments change over time with technology, pediatric emergency specialists are continuously challenged to observe possible trends and prevent more injuries by educating the

Aethlon Medical Announces Avian Flu Treatment Application
Genetic Engineering News - Aethlon Medical, Inc., (OTCBB:AEMD), a pioneer in developing therapeutic devices for infectious disease, announced today that it is expanding the applications of its Hemopurifier(TM) treatment technology to include the H5N1 strain of the Avian Flu

Thursday, February 16, 2006


Hepatitis C Information - Liver Cancer, Hepatitis C Connection Gets Clearer


Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets ClearerCategory: Health NewsCreated: 12/8/2005 1:59:00 AMLast Editorial Review: 12/8/2005 1:58:50 AM

SCH 503034 Jumps on the Fast Track
Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development....

Hepatitis C
Title: Hepatitis CCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 9/17/2005

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A InfectionCategory: Health NewsCreated: 7/13/2005 1:58:00 AMLast Editorial Review: 7/13/2005 1:58:14 AM

Wednesday, February 15, 2006


Hepatitis C Information - Enzo Biochem Shareholders Elect Three Directors at Annual Meeting


Enzo Biochem Shareholders Elect Three Directors at Annual Meeting
Genetic Engineering News, NY - Jan 19, 2006... of its proprietary gene medicine for HIV-1 infection and its proprietary immune regulation medicines for hepatitis B and hepatitis C infection and for Crohn's ...

Transgene Awarded EUR 1.3 M Grant for Hepatitis C Therapeutic ...
Canada NewsWire (press release), Canada - Jan 25, 2006... About Hepatitis C: Hepatitis C infection is a major public health problem with around 170 to 200 million people infected worldwide. ...

ZymoGenetics Reports Fourth Quarter and Year End 2005 Financial ...
International News Service, Australia - Feb 9, 2006... Other -- The company decided to advance Interleukin-29 (IL-29) into clinical development as a potential treatment for Hepatitis C infection. ...

Koronis Pharmaceuticals to Participate in Panel 'Infectious ...
PR Newswire (press release), NY - Feb 9, 2006... to the Company's lead product candidate, KP-1461 for AIDS/HIV, the Company has product candidates in development for the treatment of hepatitis C infection. ...

Tuesday, February 14, 2006


Hepatitis C Information - Vitamins Suggested During Combination Therapy


Vitamins Suggested During Combination Therapy
A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy....

Feedster
No Need to Click Here - I'm just claiming my feed at Feedster....

Alcoholism Facts
Title: Alcoholism FactsCategory: Health FactsCreated: 8/9/2005Last Editorial Review: 8/29/2005

Shorter Therapy Effective for Genotypes 2 and 3
Genotypes 2 and 3 are much more responsive to current interferon combination therapies. This report details studies that show a shorter course of treatment might be just as effective as longer courses. Researchers continue to refine treatment protocols for HCV...

Ultrasound
Title: UltrasoundCategory: Procedures and TestsCreated: 12/31/1997Last Editorial Review: 10/15/2005

Hepatitis C Information - Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program


Peregrine Announces Acceleration of Its Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program
[Press Release] PR Newswire via Yahoo! Finance - Jan 18 4:00 AM
Peregrine Pharmaceuticals, Inc. , a biopharmaceutical company with a portfolio of innovative, clinical-stage product candidates for viral diseases and cancer, today announced that it has accelerated its clinical program for Tarvacin Anti-Viral for the treatment of chronic hepatitis C virus infection .Save to My Web

Monday, February 13, 2006


Hepatitis C Information - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.


Sunday, February 12, 2006


Hepatitis C Information - Proposal to give free pipes to crack addicts


Proposal to give free pipes to crack addicts
Scotsman, United Kingdom - Feb 8, 2006... co-ordinator, suggested that specially-made glass pipes should be given to addicts at the taxpayers' expense to cut the risk of tuberculosis and hepatitis C. ...

FSU study of hepatitis C virus solves mystery that has stymied ...
Florida State University, Florida - Feb 8, 2006by Libby Fairhurst. The hepatitis C virus (HCV) infects more than 170 million people worldwide and leads to both acute and chronic liver diseases. ...

Police admit officers falsified arrest report
Tampa Bay's 10, FL - Feb 10, 2006... arrested. The police report, which Neal saw for the first time last week, said he had HIV Hepatitis C and violent mental illness. ...

Vertex Takes The Lead In Hepatitis C Race
Forbes - Feb 8, 2006... after the drug discovery company reported fourth-quarter results and announced solid clinical data for VX-950, an experimental hepatitis C treatment. ...

Vertex shoots up on hepatitis C results
MarketWatch - Feb 7, 2006BOSTON (MarketWatch) -- Shares of Vertex Pharmaceuticals shot up Tuesday after it released highly favorable clinical results for its hepatitis C drug candidate ...

Hepatitis C Information - Hepatitis C: Early Detection Means Better Health(NC)-Experts estimate

Hepatitis C: Early Detection Means Better Health

(NC)-Experts estimate that 240,000 people in Canada are currently infected with hepatitis C, of whom only 30% know they have the virus. The only way to find out for sure if you have hepatitis C is through a blood test. Your doctor can order one for you. By taking this action you'll be doing yourself a favour because hepatitis C can be treated only if it has been detected. Untreated hepatitis C can lead to severe conditions that require long-term, intensive care.

For more information visit Health Canada's Web site at www.healthcanada.ca/hepc.

About The Author

News Canada provides a wide selection of current, ready-to-use copyright free news stories and ideas for Television, Print, Radio, and the Web.

News Canada is a niche service in public relations, offering access to print, radio, television, and now the Internet media, with ready-to-use, editorial "fill" items. Monitoring and analysis are two more of our primary services. The service supplies access to the national media for marketers in the private, the public, and the not-for-profit sectors. Your corporate and product news, consumer tips and information are packaged in a variety of ready-to-use formats and are made available to every Canadian media organization including weekly and daily newspapers, cable and commercial television stations, radio stations, as well as the Web sites Canadians visit most often. Visit News Canada and learn more about the NC services.